UW-Madison testing COVID-19 vaccine in children 6 months to 4 years old – Wisconsin Public Radio News

As children ages 5 to 11 begin to get vaccinated against COVID-19, even younger kids are participating in clinical trials that will determine if they will be able to get similar protection against the disease in the near future.

This week, the University of Wisconsin School of Medicine and Public Healthannounced a phase 3 clinical trial of the Moderna vaccine in kids ages 6 months to 4 years old had filled up. The trial has been underway for two weeks.

"Weve had an overwhelming response from the Madison community," said Dr. Bill Hartman. "So, we had way more people interested in the study than we had spots."

Hartman is co-principal investigator of the KidCOVE clinical trial at UW-Madison, which also tested the Moderna vaccine on children ages 5 to 11.

So far, the Pfizer vaccine is the only brand approved for that age group. Moderna could seek emergency use authorization for children ages 5 to 11 next month, Hartman said.

The parents of 4-year-old twins Sam and Theo Rodriguez were eager to participate in the study for the sake of science and to protect their family. The children started school this fall and their grandmother, who has diabetes and COPD, lives with them at their home in eastern Dane County.

No one in the family has ever participated in clinical trial before, said their mother, Anne Rodriguez. But she said they were watching for this opportunity in hopes of potentially getting early access to a vaccine for their young children.

Hartman expects the Moderna clinical trial in these younger children to be finished in mid-December. Pfizer is further along in testing its vaccine on children under age 5, but federal approval isnt expected until 2022.

Read more here:

UW-Madison testing COVID-19 vaccine in children 6 months to 4 years old - Wisconsin Public Radio News